Hrt Financial LP Tempest Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$3.16 - $4.66 $41,206 - $60,766
13,040 New
13,040 $50,000
Q3 2023

Nov 13, 2023
BUY
$0.3 - $1.39 $8,984 - $41,627
29,948 New
29,948 $9,000

Others Institutions Holding TPST

# of Institutions
28
Shares Held
1.72M
Call Options Held
30K
Put Options Held
80.5K
View Full List

About Tempest Therapeutics, Inc.

TPST Quotes by TradingView
  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $14.2M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email